Wednesday, May 8, 2024

Another Chinese formula scandal

Avatar photo
Chaotic sales channels have been blamed for China’s latest fake infant formula scandal where 22,600 cans of counterfeit milk powder were sold under the brands of Chinese infant formula maker Beingmate and US-based Abbott Laboratories.
Reading Time: 3 minutes

Fonterra has a close association with both – it invested in an 18.8% stake in Beingmate last year and is jointly developing a new dairy farm hub in China with Abbott.

Nine people were arrested over the weekend and charged with making and selling fake products in seven provinces. Chinese media reported they were all long-time formula distributors who were familiar with production processes.

Wang Dingmian, former director of the Dairy Association of China, said chaotic sales channels in China’s dairy industry were responsible for the problem, whereas in countries like Australia supermarkets usually purchased products directly from manufacturers with no traders involved.

The bust has worsened Chinese consumers’ already fragile trust in domestic infant milk formula following the 2008 melamine scandal involving Fonterra’s partner Sanlu, in which six babies died.

Christina Zhu, Fonterra’s managing director Greater China, said the government had been clear the latest case was a criminal issue and the companies involved had taken a responsible approach to it.

Although industry experts have absolved the two companies of blame, they have suggested it could cause long-term brand damage to the pair, which were among China’s biggest infant formula brands.

“We have been monitoring the media and social media commentary carefully and at this stage there is no reason for us to believe there will be any long-term impacts from it,” Zhu said.

Shenzen-listed Beingmate has already suffered two consecutive years of revenue decline, reporting a 10% sales drop last year. However, earnings rose 50%, recovering from a 90% fall the year before. Its share price is 11.91 yuan, significantly below the 18 yuan apiece Fonterra paid for its 18.8% stake last year.

Zhu, who is on the Beingmate board, said the investment’s rationale remained, which included infant formula forecast to rise by 10-15% following last year’s relaxation of China’s one-child policy.

Beingmate’s share price reflected a drop in China’s capital markets and Zhu said she was more interested in its operational performance.

The company had been working hard on a turnaround with the latest results showing a stronger second half performance.

“That’s no accident,” she said. “In the final quarter there was a big pick-up on the previous quarter.”

Finalising details of the distribution agreement for Fonterra’s Anmum brand, which has been in the Chinese market since 2013, and the Darnum joint venture in Australia took longer than expected, she said. Fonterra announced in February, subject to regulatory approvals, the first product destined for Beingmate’s Chinese customers would roll off the Darnum line in the second half of this year.

“Beingmate is not just important for Fonterra, this distribution agreement is an important part of the portfolio for Beingmate,” she said, because of the Chinese consumer preference for foreign brands.

There had been rapid growth of cross-border e-commerce sites, with Chinese consumers preferring to buy overseas-branded formula online rather than from local franchised stores which were viewed as less safe.

Chinese authorities had already signalled tighter regulations on infant formula which in the medium- to long-term was expected to boost larger domestic operators such as Beingmate and foreign brands which mainly relied on offline channels and business-to-consumer flagship stores.

Zhu said Beingmate was well-placed to pick up market share once the new regulations were enforced. Morgan Stanley analysts had also named Beingmate and Yashili as potential beneficiaries.

The new regulations were two-pronged, relating to cross-border e-commerce and registration.

Cross-border e-commerce involved direct parcel delivery, someone bringing the goods in their suitcase, and free-trade or bonded zone importation where an importer brought in a container then shipped out individual parcels to consumers.

Previously these models incurred a personal postal articles tax which for food products was 10%. Two regulations introduced on April 8 aimed to level the playing field between cross-border e-commerce and the general trade where importers pay import tariffs and value added tax of about 17%.

For food products, the personal postal articles tax had lifted to 15%. The authorities also introduced a new “positive” list for goods entering free trade zones with value limits on purchases of 2000 RMB per shipment and 20,000 RMB per person annually. Food items that fall within the value limit attract an 11.9 % tax but those that went above the value limits would incur the general trades tax of 17%.

All Fonterra’s consumer brands were on the positive list and Zhu said the impact would be minimal given less than 1% of its products were sold through e-commerce channels.

Chinese authorities also filed an updated WTO notification in January signalling domestic and imported infant formula would have to be registered by January 2018 with the CFDA (China Food and Drug Administration). It’s thought likely it would include those sold through cross-border e-commerce channels.

The new regulations mean one company could produce only three brands with nine formulae and proper Chinese labelling was required. They were expected to reduce the number of domestic formula brands on sale from more than 2000 to about 400. Two years ago Chinese authorities slashed the number of foreign infant formula brands that could be sold in the country from more than 800 to about 94.

Analysts expected the whole market to suffer in the near term as sellers leaving the market lowered prices to shed inventory.

Zhu said the timing kept changing for the release of the detailed regulations, which were still being drafted.

Total
0
Shares
People are also reading